Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2017 | 1 |
2021 | 2 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial.
Lancet Oncol. 2023 Aug;24(8):868-880. doi: 10.1016/S1470-2045(23)00265-6. Epub 2023 Jul 6.
Lancet Oncol. 2023.
PMID: 37423227
Free article.
Clinical Trial.
Quality assurance of dysphagia-optimised intensity modulated radiotherapy treatment planning for head and neck cancer.
Tyler J, Bernstein D, Seithel M, Rooney K, Petkar I, Miles E, Clark CH, Hall E, Nutting C.
Tyler J, et al.
Phys Imaging Radiat Oncol. 2021 Oct 26;20:46-50. doi: 10.1016/j.phro.2021.10.003. eCollection 2021 Oct.
Phys Imaging Radiat Oncol. 2021.
PMID: 34754954
Free PMC article.
Item in Clipboard
Dysphagia-optimised Intensity-modulated Radiotherapy Techniques in Pharyngeal Cancers: Is Anyone Going to Swallow it?
Petkar I, Bhide S, Newbold K, Harrington K, Nutting C.
Petkar I, et al.
Clin Oncol (R Coll Radiol). 2017 Jul;29(7):e110-e118. doi: 10.1016/j.clon.2017.02.002. Epub 2017 Feb 24.
Clin Oncol (R Coll Radiol). 2017.
PMID: 28242166
Free article.
Review.
Item in Clipboard
Inter-Observer Variation in Delineating the Pharyngeal Constrictor Muscle as Organ at Risk in Radiotherapy for Head and Neck Cancer.
Petkar I, McQuaid D, Dunlop A, Tyler J, Hall E, Nutting C.
Petkar I, et al.
Front Oncol. 2021 Mar 9;11:644767. doi: 10.3389/fonc.2021.644767. eCollection 2021.
Front Oncol. 2021.
PMID: 33768005
Free PMC article.
Item in Clipboard
Dysphagia-optimised intensity-modulated radiotherapy versus standard radiotherapy in patients with pharyngeal cancer - Authors' reply.
Nutting C, Finneran L, Roe J, Petkar I, Rooney K, Hall E; DARS Triallist Group.
Nutting C, et al.
Lancet Oncol. 2023 Oct;24(10):e398. doi: 10.1016/S1470-2045(23)00457-6.
Lancet Oncol. 2023.
PMID: 37797636
No abstract available.
Item in Clipboard
DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer.
Petkar I, Rooney K, Roe JW, Patterson JM, Bernstein D, Tyler JM, Emson MA, Morden JP, Mertens K, Miles E, Beasley M, Roques T, Bhide SA, Newbold KL, Harrington KJ, Hall E, Nutting CM.
Petkar I, et al.
BMC Cancer. 2016 Oct 6;16(1):770. doi: 10.1186/s12885-016-2813-0.
BMC Cancer. 2016.
PMID: 27716125
Free PMC article.
Item in Clipboard
Cite
Cite